[HTML][HTML] Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes
A Petruzziello, S Marigliano, G Loquercio… - World journal of …, 2016 - ncbi.nlm.nih.gov
METHODS We conducted a systematic study which represents one of the most
comprehensive effort to quantify global HCV epidemiology, using the best available …
comprehensive effort to quantify global HCV epidemiology, using the best available …
[HTML][HTML] Global epidemiology and genotype distribution of the hepatitis C virus infection
The treatment of chronic hepatitis C virus (HCV) infection has the potential to change
significantly over the next few years as therapeutic regimens are rapidly evolving. However …
significantly over the next few years as therapeutic regimens are rapidly evolving. However …
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
MS Sulkowski, DF Gardiner… - … England Journal of …, 2014 - Mass Medical Soc
Background All-oral combination therapy is desirable for patients with chronic hepatitis C
virus (HCV) infection. We evaluated daclatasvir (an HCV NS5A replication complex inhibitor) …
virus (HCV) infection. We evaluated daclatasvir (an HCV NS5A replication complex inhibitor) …
Epidemiology and natural history of HCV infection
Abstract Worldwide, an estimated 130–170 million people have HCV infection. HCV
prevalence is highest in Egypt at> 10% of the general population and China has the most …
prevalence is highest in Egypt at> 10% of the general population and China has the most …
[HTML][HTML] EASL Clinical Practice Guidelines: management of hepatitis C virus infection
European Association For The Study Of The Liver - Journal of hepatology, 2014 - Elsevier
Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease
worldwide. The long-term impact of HCV infection is highly variable, from minimal changes …
worldwide. The long-term impact of HCV infection is highly variable, from minimal changes …
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis
BR Yehia, AJ Schranz, CA Umscheid, V Lo Re III - PloS one, 2014 - journals.plos.org
Background Identifying gaps in care for people with chronic hepatitis C virus (HCV) infection
is important to clinicians, public health officials, and federal agencies. The objective of this …
is important to clinicians, public health officials, and federal agencies. The objective of this …
[HTML][HTML] Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study
The present study was designed to determine the seroprevalence of hepatitis B and C virus
(HBV, HCV) infections and risk factors in the Turkish general population. Participants were …
(HBV, HCV) infections and risk factors in the Turkish general population. Participants were …
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
R Bartenschlager, V Lohmann, F Penin - Nature Reviews Microbiology, 2013 - nature.com
The availability of the first molecular clone of the hepatitis C virus (HCV) genome allowed
the identification and biochemical characterization of two viral enzymes that are targets for …
the identification and biochemical characterization of two viral enzymes that are targets for …
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
Background An unmet need exists for interferon-free and ribavirin-free treatments for chronic
hepatitis C virus (HCV) infection. In this study, we assessed all-oral therapy with daclatasvir …
hepatitis C virus (HCV) infection. In this study, we assessed all-oral therapy with daclatasvir …
Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions
Egypt is the most affected nation by hepatitis C virus (HCV) and needs a comprehensive
characterization of HCV epidemiology to inform the scale-up of treatment and prevention …
characterization of HCV epidemiology to inform the scale-up of treatment and prevention …